| E. COLI | Monitoring | 0 | N/A | Aug 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Aug 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jan 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Aug 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 62.1475 | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 62.4425 | Sep 30, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Aug 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Aug 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 89.7 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 89.7 | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 75.87 | Sep 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Aug 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Surface Water Treatment Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 67.73 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 92.9275 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 92.9275 | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 73 | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 157 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 128.3167 | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 60.6333 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 60.6333 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| TTHM | Health-Based | N/A | 110.92 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 110.92 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 95.5 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 99.975 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 148.2333 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 104.6667 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 95.7525 | Dec 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 95.7525 | Dec 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 95.7525 | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 97.75 | Dec 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 92 | Dec 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 78.5 | Dec 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 111.175 | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 95 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 95 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 95 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 31, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |